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Background: Findings from animal and epidemiological research support the potential
neuroprotective benefits from healthy diets. However, to establish diet-neuroprotective
causal relations, evidence from dietary intervention studies is needed. NU-AGE is the first
multicenter intervention assessing whether a diet targeting health in aging can counteract
the age-related physiological changes in different organs, including the brain. In this study,
we specifically investigated the effects of NU-AGE’s dietary intervention on age-related
cognitive decline.
Materials and Methods: NU-AGE randomized trial (NCT01754012, clinicaltrials.gov)
included 1279 relatively healthy older-adults, aged 65–79 years, from five European
centers. Participants were randomly allocated into two groups: “control” (n = 638),
following a habitual diet; and, “intervention” (n = 641), given individually tailored
dietary advice (NU-AGE diet). Adherence to the NU-AGE diet was measured over
follow-up, and categorized into tertiles (low, moderate, high). Cognitive function was
ascertained at baseline and at 1-year follow-up with the Consortium to Establish a
Registry for Alzheimer’s Disease (CERAD)-Neuropsychological Battery and five additional
domain-specific single cognitive tests. The raw scores from the CERAD subtests
[excluding the Mini-Mental State Examination (MMSE)] and the single tests were
standardized into Z-scores. Global cognition (measured with MMSE and CERAD-total
score), and five cognitive domains (perceptual speed, executive function, episodic
memory, verbal abilities, and constructional praxis) were created. Cognitive changes as
a function of the intervention were analyzed with multivariable mixed-effects models.
Results: After the 1-year follow-up, 571 (89.1%) controls and 573 (89.8%) from
the intervention group participated in the post-intervention assessment. Both control
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and intervention groups showed improvements in global cognition and in all cognitive
domains after 1 year, but differences in cognitive changes between the two groups were
not statistically significant. However, participants with higher adherence to the NU-AGE
diet showed statistically significant improvements in global cognition [β 0.20 (95%CI
0.004, 0.39), p-value= 0.046] and episodic memory [β 0.15 (95%CI 0.02, 0.28), p-value
= 0.025] after 1 year, compared to those adults with lower adherence.
Discussion: High adherence to the culturally adapted, individually tailored, NU-AGE diet
could slow down age-related cognitive decline, helping to prevent cognitive impairment
and dementia.
Keywords: randomized controlled trial, dietary intervention, cognitive decline, multicenter, neuroprotective,
episodic memory, healthy diet
INTRODUCTION
Dementia has become a worldwide public health priority. About
47 million people are living today with dementia around the
world and this number is expected to increase three-fold, up
to 132 million cases by 2050 (Prince et al., 2015). Currently,
treatment to cure dementia, or its preclinical stages, is not
available and preventative strategies are still under debate.
Lifestyle modification appears to be a promising alternative
strategy to slow the progression of cognitive decline and thus, to
prevent dementia (Winblad et al., 2016).
Emerging evidence from observational studies suggests that
healthy dietary habits could have neuroprotective benefits. A
slower rate of cognitive decline and reduced risk of cognitive
impairment and dementia have been associated with a higher
consumption of single nutrients (e.g., vitamins B–E, tocopherol,
polyunsaturated omega-3 fatty acids, polyphenols; Mangialasche
et al., 2010, 2013; Gillette-Guyonnet et al., 2013; Hooshmand
et al., 2014) or of single foods (e.g., olive oil, vegetables,
fruits, nuts, red wine, and fish; Devore et al., 2012; Caracciolo
et al., 2014). However, people eat combinations of foods, which
may have additive, synergistic, or antagonistic effects on health
(Jacobs et al., 2009). Therefore, using a whole-diet approach,
which emphasizes the overall dietary intake, is more important
when seeking for preventive strategies targeting multifactorial
disorders, such as dementia.
In the last half century, the Mediterranean diet, traditionally
widespread across the Mediterranean Sea countries (e.g., Italy,
Greece, Egypt, Libya), has been extensively investigated in
relation to several health outcomes, making it a potential model
of a healthy and sustainable diet (Dernini and Berry, 2015;
Boccardi et al., 2018). The Mediterranean diet is characterized by
a high intake of plant-based foods (i.e., vegetables, fruits, whole
grain, cereals, legumes, nuts, and seeds); olive oil as the main
source of fat; low-to-moderate consumption of dairy products,
fish, and poultry; and low intake of red meat and red wine
during meals (Boccardi et al., 2018). Greater adherence to the
Mediterranean diet has been related to decreased risks of several
age-related health conditions, such as metabolic, cardiovascular,
and cerebrovascular disorders, cancer (Ostan et al., 2015), and
mortality (Yannakoulia et al., 2015), but also cognitive decline
(Trichopoulou et al., 2015), cognitive impairment (Psaltopoulou
et al., 2013), and dementia (Scarmeas et al., 2006; Singh et al.,
2014). Similar results were also observed in the few population-
based studies which have used culturally adaptedMediterranean-
like dietary patterns such as the MIND diet (Morris et al., 2015),
the Prudent diet (Shakersain et al., 2016), and the Baltic Sea Diet
(Kanerva et al., 2014).
Despite the encouraging findings from these observational
studies, evidence from dietary intervention randomized
controlled trials (RCTs) is lacking in healthy older adults,
which is needed in order to establish diet-neuroprotective
causal relationships. NU-AGE is the first multicenter whole-
diet intervention assessing whether a diet targeting national
nutritional recommendations for older adults can counteract
inflammaging and age-related physiological changes in different
organs, including the brain. Specifically, in the current study,
we investigated the effects of NU-AGE’s dietary intervention on
cognitive functioning in relatively healthy older adults from five
different European countries.
MATERIALS AND METHODS
Study Design and Participants
NU-AGE (http://www.nu-age.eu/) is a 1-year, multicenter,
randomized, single-blind, controlled trial (registered with
clinicaltrials.gov, NCT01754012) with two parallel groups (i.e.,
dietary intervention and control) carried out during April 2012–
January 2015 in five European centers in France, Italy, the
Netherlands, Poland, and the United Kingdom (UK) (Berendsen
et al., 2014). The recruitment of participants has been described
in detail previously (Berendsen et al., 2014; Santoro et al.,
2014). Briefly, 2,668 volunteers from the community aged 65–
79 years, free of major overt chronic diseases for at least 2 years
(e.g., cancer, severe organ disease), living independently, and
free of dementia, were recruited to participate in the baseline
assessment. At enrollment, exclusion criteria included severe
heart diseases, type 1 and insulin-treated type 2 diabetes, chronic
use of corticosteroids, recent use of antibiotics, change in habitual
medication use, frailty (Fried et al., 2001), malnutrition [body
mass index (BMI) <18.5 kg/m2 or 10% weight loss within 6
months], or food allergy/intolerance requiring special diets. Of
the 2,665 participants, 1512 were screened for inclusion and
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1,296 were eligible to participate in the NU-AGE trial. In this
study, 1,279 participants [intention-to-treat (ITT) population]
who completed the baseline cognitive assessment were randomly
assigned (1:1) to the control (n = 641) or intervention (n =
638) groups, after stratification by sex, age (65–72 or >72–79
years), frailty status (pre-frail or non-frail), and BMI (<25 or
≥25 kg/m2). Randomization was done by computer-generated
allocation. Participants were informed about their study group
after randomization.
Written informed consent was collected from all participants
prior to their inclusion in the study, in accordance with
the Declaration of Helsinki. NU-AGE was approved by the
ethics committee of the coordinator center—the Independent
Ethics Committee of the S. Orsola-Malpighi Hospital Bologna
(Italy)—and by the local/national ethics committees of all
the other four recruiting centers—the South-East 6 Person
Protection Committee (France), the Wageningen University
Medical Ethics Committee (Netherlands), the National Research
Ethics Committee–East of England (UK), and the Bioethics
Committee of the Polish National Food and Nutrition Institute
(Poland).
Procedures
Before recruitment started, dieticians, research nutritionists, and
research assistants from the five recruiting centers participated
in structured in-depth training for recruitment, data collection
(e.g., how to administer questionnaires; assess nutritional,
physical, and cognitive assessment; collect specimen samples),
and dietary intervention. At baseline and 1-year of follow-
up, trained personnel (i.e., research assistants, dieticians, or
research nutritionist), who were blinded to the study group,
collected information on demographics (i.e., age, sex, education),
medical conditions, and medication use at each research
center through structured interviews and questionnaires. Among
several parameters collected (Santoro et al., 2014), weight, height,
and blood pressure weremeasured by a trained research assistant.
Blood, urine, and fecal samples were collected, handled, and
stored from all participants. Education was categorized into
elementary, secondary (including lower and upper secondary),
and college/university based on years of full-time education.
Weight and height were measured while participants wore light
clothes and no shoes. Country of enrollment was categorized
into “France,” “Holland,” “Italy,” “Poland,” and “UK.” BMI was
calculated as weight in kilograms divided by squared height in
meters (kg/m2) and classified as underweight (<20), normal
weight (20–25), overweight (25–30), and obese (≥30). Frailty
was based on the five criteria proposed by Fried and colleagues
(Fried et al., 2001), including weight loss, weakness (i.e., poor
handgrip strength), self-reported exhaustion, slowness (i.e., slow
gait speed), and low physical activity. Weight loss was defined as
self-reported unintentional loss (i.e., not due to diet or physical
exercise) of ≥4.5 kg in the last 12 months. Handgrip strength
was measured three times in the dominant hand using the
Scandidact Smedley’s Hand Dynamometer R© (Odder, Denmark).
Weakness was defined as the average handgrip strength equal
or below the sex- and BMI-specific cutoffs provided by Fried
and colleagues (Fried et al., 2001). Two questions from the
Center for Epidemiologic Studies Depression (CES-D) scale were
administered as measures of exhaustion: “I felt that everything I
did was an effort” and “I could not get going” (Gray et al., 2013;
Sousa-Santos et al., 2018). Self-reported exhaustion was present
if at least one condition was present for ≥3 days in the past
week. Gait speed was measured by asking participants to walk
at their usual speed over 4.6m (Sousa-Santos et al., 2018). Slow
gait was defined as walking equal to or above the sex- and height-
specific validated cutoffs (Fried et al., 2001). Physical activity
was determined based on weekly rates of energy expenditure
(kcal/week), derived from the modified Minnesota Leisure Time
Activity Questionnaire, in which participants were asked about
frequency and duration of time spent in 18 activities over the
past 2 weeks (Taylor et al., 1978; Siscovick et al., 1997). Low
physical activity was defined as <383 kcal for men or <270 kcal
for women, according to sex-specific cutoffs (Fried et al., 2001).
Pre-frailty was defined as the presence of 1 or 2 of the above
criteria. Medical conditions were self-reported, but verified, when
possible, by the recruiting staff by asking the participants to bring
their medical documents and current drug boxes to the visit. In
some cases, the staff was authorized by the participants to contact
their general practitioner for further health information. Medical
conditions included sensory disorders (e.g., impaired vision,
hearing, olfactory, or taste), hypertension, hypercholesterolemia,
cardiovascular and cerebrovascular diseases, neurological and
mental health issues, thyroid dysfunction, osteoporosis, and
arthritis.
Dietary Intervention and Controls
Details on the dietary intervention, control group, and
dietary intake assessments were reported previously (see
Berendsen et al., 2014). In brief, all participants (randomized
into control and intervention groups) completed a seven-
day food record for seven consecutive days over 2 weeks
after the baseline assessment, and had an interview with a
trained dietician/research nutritionist to review the records.
The consumed foods recorded in the food record were
coded according to standardized coding procedures (Berendsen
et al., 2014). The control group, following a habitual diet,
received only a leaflet with national dietary guidelines. The
intervention group followed the NU-AGE diet, which consisted
of individually tailored Mediterranean-like diet advice targeting
dietary recommendations for older adults from the five included
countries (see Berendsen et al., 2014 for more information
on the NU-AGE nutritional reccomandations). Participants in
the diet group also received individual education by means
of monthly telephone contacts and face-to-face meetings with
a dietician/nutritionist. In particular, at months 4 and 8
the dietician/nutritionist used the Motivational Interviewing
technique during nutritional counseling to help supporting
participants to meet the NU-AGE Food Based Dietary Guidelines
(FBDG). Additionally, to increase adherence, participants in the
intervention group received free food, meeting the NU-AGE
guidelines [e.g., whole grain pasta, margarine rich in PUFA and
MUFA, low fat, low-salt cheese, extra virgin olive oil and frozen
vegetable soup (Italy only)]. A NU-AGE index was constructed
to measure the participant’s level of adherence to the to the
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NU-AGE’s FBDG, both at baseline and post-intervention (details
on the adherence indices are reported in Berendsen et al.,
under review).
Assessment of Cognitive Functioning
A comprehensive cognitive test battery was administered by
trained personnel (who were blinded to the participant’s assigned
group), in a fixed order, at baseline and 1-year of follow-up.
The battery included the Consortium to Establish a Registry
for Alzheimer’s Disease neuropsychological battery [CERAD-NB,
which included the Mini Mental State Examination (MMSE)]
(Morris et al., 1989), Babcock Story Recall Test (BSRT) (Babcock
and Levy, 1940), Pattern Comparisons (Salthouse and Babcock,
1991), Digit Cancellation (Zazzo, 1974), and Trail Making Test
(TMT) (Lezak et al., 2012). These tests covered the major
cognitive functions and were sensitive enough to detect small-to-
moderate differences in cognition in normal aging (Lezak et al.,
2012).
The Mini-Mental State Examination (MMSE) is a 30-point
screening tool, commonly used in clinical and research settings
to assess global cognitive function (Folstein et al., 1975; Lezak
et al., 2012). Due to its global nature and being a brief
cognitive screening tool, the MMSE was used on its own in the
current study (Chandler et al., 2005). Therefore, the CERAD-NB
consisted of seven subtests. The Category fluency task required
participants to name as many animals as possible and is scored
as the number of correct unique words generated in 60 s. In
the 15-items Boston Naming Test (15-BNT), participants were
instructed to name 15 objects, ranging in frequency of occurrence
(low, medium, or high), presented as line drawings in a flipbook.
The number of correctly named objects was recorded. TheWord
List Memory (WLM) test consisted of three tasks: immediate
and delay recall, and recognition. Participants were shown ten
consecutive and unrelated words over three trials and instructed
to read each word aloud and then to remember as many words
as possible (immediate recall). The total score was the sum of
items correctly recalled over the three trials. After approximately
5min, participants were asked to recall the 10 words, recording
the maximum number of correct responses (delay recall). Next,
participants were asked to recognize the 10 words from a list
of targets mixed with unrelated distractors (recognition). The
recognition score was calculated as the number of correct hits
minus the number of false alarms (Laukka et al., 2013). The
Constructional Praxis test instructed participants to draw four
geometrical figures increasing in their complexity; the score was
the sum of the correct responses on the four figures (range 0–11).
In the BSRT (Babcock and Levy, 1940) participants were read
a short story consisting of an immediate and a delayed (after
20min) recall of a 21-unit paragraph presented in an organized
context. The Pattern comparisons test (Salthouse and Babcock,
1991) was scored as the number of correct classifications—“same”
or “different”—of pairs of line-segment patterns. For the Digit
Cancellation test (Zazzo, 1974), participants were instructed to
cross every “4” encountered among random digits; the score was
the number of correct 4s crossed in 30 s. TMT (Lezak et al., 2012)
is a paper-and-pencil test consisting of two similar parts, A and
B. The TMT-A requires the sequential connecting of 25 circled
numbers, while in the TMT-B the participants were instructed
to sequentially alternate numbers and letters (e.g., 1, A, 2, B).
For each part, the scores (time of performance in seconds) were
multiplied by−1, therefore higher scores always indicated better
performance. A TMT B/A ratio score was generated as a measure
of executive function independent of themotor speed component
(Lezak et al., 2012).
The MMSE and a CERAD total score (CTS), which was
calculated by summing the CERAD-NB subtest scores, were
used as measures of global cognition (Chandler et al., 2005).
Further, at each time point, raw scores from the cognitive
tests were standardized into Z-scores, using baseline means and
standard deviations (SDs). Five cognitive domains were created
using individual test Z-scores or by averaging the Z-scores of
multiple tests. The division was made a priori, according to
the standard neuropsychological practice and cognitive theory
(Lezak et al., 2012). Final cognitive domains included: (1)
Perceptual speed [Pattern comparisons, Digit cancellation]; (2)
Executive functions [Category fluency, TMT B/A ratio]; (3)
Episodic memory, resulting from the sum of “immediate” [WLM
and BSRT immediate tasks] and “delay” [WLM and BSRT
delayed tasks] recall; (4) Verbal abilities (15-BNT); and (5)
Constructional praxis (CERAD copy task). An overview of
the cognitive assessment included in NU-AGE is provided in
Table 1.
Statistical Analysis
Baseline characteristics between groups were analyzed using
chi-square tests for proportions, and t-tests, or one-way
ANOVAs for continuous variables, followed by pairwise
comparisons with Bonferroni correction. Linear mixed-effects
models, with maximum likelihood estimation and identity
covariance matrices, were used to assess mean global and
domain-specific cognitive changes between groups 1-year
TABLE 1 | Overview of the cognitive domains and related tasks in the NU-AGE
study.
Cognitive domains Cognitive tasks
Global cognition Mini-Mental State Examination
CERAD total scorea
Perceptual speedb Pattern comparisons
Digit cancellation
Executive functionb Category fluency
Trial making test B/A ratio
Episodic memoryb World List Memory—immediate and delay recall
Babcock Story Recall Test—immediate and delay recall
Verbal abilitiesb 15-items Boston Naming Test
Constructional praxisb Constructional praxis test
aCERAD total score was calculated by summing the z-scores from the following
CERAD subtests: Category fluency; 15-items Boston Naming Test; World List Memory—
immediate and delay recall; World List Memory—recognition task; and, Constructional
praxis test.
bComposite cognitive domains were created by averaging the z-scores of the cognitive
tasks reported in the second column. Constructional praxis was based on the individual
praxis test z-score.
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after randomization. Each cognitive measure was used as a
separate outcome. The fixed effects included group (control
vs. intervention), linear time (baseline vs. 1-year follow-up),
and their interaction (group × time). The random effects
included random intercept and slope for time, allowing for intra-
individual differences in cognitive performance at baseline and
over time. Mixed-effects models were also employed to examine
the association between adherence to NU-AGE diet and cognitive
changes within the intervention group. The NU-AGE index
was divided into tertiles (low, moderate, high), with the lowest
tertile (lowest adherence) being used as the reference category.
Baseline age, sex, education, enrollment country, interviewer,
baseline adherence in tertiles, BMI, and medical conditions were
considered as potential confounders. The primary analyses were
based on the ITT population.
In supplementary analyses, we conducted modified intention-
to-treat analysis (mITT), which included participants with
complete cognitive data at baseline and the follow-up
examination. Country-related differences in cognitive changes
over 1-year of follow-up were investigated in stratified analyses
by enrollment country. We further performed stratified analyses
by baseline (1) cognitive functioning (cognitive impairment
[MMSE <27] vs. cognitively intact [MMSE ≥27]); (2) frailty
status; and 3) educational attainment [low (primary plus lower
secondary) vs. high (upper secondary plus college)].
Two-tailed p values≤0.05 were deemed statistically significant
in all analyses. Stata SE, version 14.0 (StataCorp LP., College
Station, Texas, USA) was used in all data analyses.
RESULTS
Characteristics of Study Participants
At baseline, the average age of the 1,279 participants was 70.9 ±
3.4 years, and 720 (56.3%) were female. Each center recruited
a similar proportion of participants [France, n = 210 (16.4%);
the Netherlands, n = 252 (19.7%); Italy, n = 298 (23.3%);
Poland, n = 252 (19.7%); and UK, n = 267 (20.9%)]. Baseline
demographic, health-related, and cognitive characteristics of
study participants were overall balanced (Table 2, Supplementary
Table 1). However, participants in the intervention group were
more likely to be slightly younger, pre-frail, and to have a
higher proportion of mental health conditions. After 1 year,
1,144 (89.4%) participated at the follow-up assessment, of whom
571 (89.1%) were controls and 573 (89.8%) were from the
intervention group. Both control and intervention groups tended
to have improvements in global cognition and in all cognitive
domains, but differences were not statistically significant between
groups (Supplementary Table 1).
During the 1-year intervention, 135 individuals withdrew
from the study, because of the inability to follow the diet,
difficulties to attend the 12-months visit, restrictiveness of dietary
intervention, or issues of health or in the family. Compared to
participants, dropouts had lower education, higher BMI, more
sensorial impairment, cardiovascular diseases, osteoporosis, and
lower cognitive function (mean MMSE score was 27.8 ± 2.0 for
dropouts vs. 28.3 ± 1.6 for participants) at baseline. The highest
proportion of dropouts were shown among participants in Italy
(n= 56, 41.5%).
TABLE 2 | Baseline demographics and health characteristics of NU-AGE study





n = 641 n = 638
Age, years 1279 71.1 ± 0.2 70.7 ± 0.2 0.052
Female sex 1279 353 (55.1) 367 (57.5) 0.376
Education 1242
Elementary 25 (4.0) 16 (2.6)
Secondary 303 (49.0) 301 (48.3) 0.309
College/University 291 (47.0) 306 (49.1)
Country 1279
France 105 (16.4) 105 (16.5)
Holland 129 (20.1) 123 (19.3)
Italy 152 (23.7) 146 (22.9) 0.981
Poland 124 (19.3) 128 (20.1)
UK 131 (20.4) 136 (21.3)
Baseline adherenceb 1232 51.5 ± 10.1 51.5 ± 9.56 0.956
MMSE 1243 28.3 ± 1.59 28.2 ± 1.68 0.188
Frailty status 1142
Non-frail 466 (81.8) 434 (75.9) 0.015
Pre-frail 104 (18.3) 138 (24.1)
HbA1c, % 1227 5.8 ± 0.02 5.8 ± 0.02 0.835
Body-mass
index, kg/m2
1277 26.7 ± 0.1 26.8 ± 0.2 0.613
Underweight [<20] 13 (2.0) 9 (1.4)
Normal [20-25] 201 (31.5) 225 (35.3)
Overweight [25-30] 304 (47.6) 280 (43.9) 0.376
Obese [≥30] 121 (18.9) 124 (19.4)
MEDICAL CONDITIONS
Sensorial 1244 357 (57.6) 343 (55.0) 0.353
Hypertension 1245 249 (40.2) 265 (42.4) 0.422
Hypercholesterolemia 1241 206 (33.4) 205 (32.9) 0.841
Cardiovascular diseases 1245 180 (29.0) 190 (30.4) 0.598
Stroke 1245 12 (1.9) 13 (2.1) 0.856
Diabetes 1245 33 (5.3) 30 (4.8) 0.674
Neurological 1244 14 (2.3) 19 (3.0) 0.388
Mental health 1241 26 (4.2) 44 (7.0) 0.030
Hyperthyroid 1244 4 (0.7) 9 (1.4) 0.169
Hypothyroid 1244 58 (9.4) 63 (10.1) 0.673
Osteoporosis 1239 68 (11.0) 79 (12.7) 0.372
Arthritis 1238 193 (31.4) 202 (32.4) 0.723
Data are presented as proportion [n (%)] or mean ± standard deviations.
HbA1c, glycated hemoglobin; MMSE, Mini-Mental State Examination.
aTwo–sample t–test (p-value < 0.05).
bBaseline adherence measures the participant’s level of adherence to the NU-AGE’s
FBDG (details reported in Berendsen et al., under review).
Effects of NU-AGE Intervention on
Cognition
Overall, the MMSE score of participants in the intervention
group improved by a mean of 0.15 points (95% CI −0.004,
0.31) in 1 year, whereas the mean MMSE change in controls
was 0.11 points (95% CI −0.05, 0.27). However, this difference
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[0.04 (95% CI −0.17, 0.26)] was not statistically significant (p
= 0.681). The basic-adjusted (by baseline age, sex, education,
enrollment country, and interviewer) trajectories of global
and domain-specific cognitive changes, 1 year after NU-AGE
dietary intervention in the ITT population, are presented in
Figure 1.
Participants in the intervention group showed a tendency
toward improved performance on the CTS and in executive
function compared to controls at 1-year follow-up. However,
the 1-year changes in the mean differences for the CTS and
the Z-scores of the cognitive domains were not statistically
significant (Table 3). Results remained similar after fully-
adjusting for baseline age, sex, education, enrollment country,
interviewer, pre-frailty, BMI, and medical conditions (data not
shown).
NU-AGE Diet Adherence and Cognitive
Improvements
At baseline, participants in the control and intervention
groups showed similar dietary habits (measured with adherence
to the NU-AGE’s FBDG) (Table 2). As expected, after 1-
year intervention, participants in the intervention group had
increased levels of adherence (mean NU-AGE index= 65.9%, SD
= 11.0) than those in the control group (mean NU-AGE index
= 52.7%, SD = 10.0) [p-value < 0.001]. Within the intervention
FIGURE 1 | Estimated trajectories of change in global and domain-specific cognitive function 1-year after randomization by group. The figure shows the changes in
global cognition (A), perceptual speed (B), executive functions (C), episodic memory (D), verbal abilities (E), and constructional praxis (F) in the control group [n
= 641; (reference); black solid line] vs. intervention group (n = 638; gray dash line). Mixed-effect models were adjusted for baseline age, sex, education, country, and
interviewer. The trajectories were plotted using the mean values of the covariates. CTS, CERAD total score.
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TABLE 3 | Estimated change in global and domain-specific cognitive functioning
1-year after randomization in control (n = 641) and intervention (n = 638) groups.
Global cognition β-Coefficient (95% confidence interval)a p-valueb
Control Intervention
CTS
Baseline 1.98 (1.07; 2.90) −0.12 (−0.22; −0.02) 0.020
Group × time 0.24 (0.18; 0.30) 0.04 (−0.04; 0.13) 0.321
Cognitive domains
Perceptual speed
Baseline 2.73 (2.02; 3.44) 0.04 (−0.3; 0.12) 0.263
Group × time 0.08 (0.04; 0.13) −0.03 (−0.09; 0.03) 0.314
Executive functions
Baseline 1.12 (0.43; 1.80) −0.11 (−0.19; −0.03) 0.010
Group × time 0.14 (0.08; 0.21) 0.02 (−0.07; 0.11) 0.698
Episodic memory
Baseline 1.13 (0.39; 1.86) −0.08 (−0.16; −0.003) 0.042
Group × time 0.17 (0.12; 0.21) 0.004 (−0.06; 0.07) 0.890
Verbal abilities
Baseline 2.27 (1.35; 3.20) 0.02 (−0.09; 0.12) 0.773
Group × time 0.17 (0.10; 0.24) −0.07 (−0.17; 0.02) 0.109
Constructional praxis
Baseline 0.10 (−0.74; 0.94) 0.02 (−0.08; 0.12) 0.688
Group × time −0.08 (−0.17; −0.001) −0.05 (−0.16; 0.06) 0.396
CTS, CERAD total score; MMSE, Mini-Mental State Examination.
aMixed-effect models were adjusted for baseline age, sex, education, center, and
interviewer.
bp-value < 0.05.
group, individuals with higher adherence to the NU-AGE diet
[second tertile (ranged 53.3–64.3) and those in the third tertile
(ranged 64.4–96.3)] showed statistically significant cognitive
improvements in global cognition [β 0.20 (95% CI 0.004, 0.39), p-
value = 0.046] and episodic memory [β 0.15 (95% CI 0.02, 0.28),
p-value = 0.025] over the follow-up, compared to older adults
with lower adherence [first tertile (ranged 25.4–53.3)] (Table 4).
Fully adjusting for covariates did not alter the results. Figure 2
shows the estimated trajectories of cognitive change in the CTS
and in episodic memory by adherence levels to the NU-AGE diet
in the intervention group.
Supplementary Analyses
Basic- and fully-adjusted mixed-effects models were repeated in
themITT population, in supplementary analyses, which included
participants with complete cognitive data at baseline and at
follow-up (n = 1144). The effect magnitude of the NU-AGE
dietary intervention on cognitive functioning was similar to the
initial analyses. We also compared controls with low adherence
to the FBDG (reference) vs. participants with moderate-to-high
adherence to the NU-AGE diet. Compared to individuals in the
control group with low adherence to the FBDG, participants
with moderate-to-high adherence to the NU-AGE diet showed
slight improvements in global cognition [β 0.06 (95% CI−0.04,
0.17)] and episodic memory [β 0.04 (95% CI −0.04, 0.11)] over
the follow-up. However, these differences were not statistically
significant.
Potential country-related differences in cognitive changes
over the 1-year follow-up were assessed. We found significant
differences in baseline demographic, health-related, and
cognitive characteristics between the five enrollment countries
(Supplementary Table 2). Therefore, a potential interaction was
examined by incorporating a three-way product term [country
× study groups (control and intervention) × time)] in the
mixed-effects models, and by stratifying by enrollment country
and study group. Results showed no significant interaction
between enrollment country and test group. We investigated
further potential interactions between test groups (control and
intervention) and baseline factors such as cognitive impairment
(cognitively healthy vs. cognitive impairment); pre-frail status
(pre-frail vs. no frail); and educational attainment (low vs.
high) in predicting cognitive changes over the 1-year follow-up
in separate mixed-effect models. In stratified analyses, the
associations between global/domain-specific cognitive changes
and test group were not statistically different among participants
with and without baseline cognitive impairment, pre-frailty, or
low education. Therefore, educational attainment, enrollment
country, baseline cognitive status, and pre-frail status did not
alter the effects of the NU-AGE dietary intervention on cognitive
function.
We repeated basic- and fully-adjusted mixed-effects models
by excluding participants with neurological and mental health
conditions at baseline (n = 103) and results were similar to the
initial analyses (data not shown).
Finally, all analyses were repeated using a second CERAD
total score, which was created by summing the seven CERAD-
NB scores from category fluency, 15-BNT, WLM (immediate
and delay recall, and recognition), and constructional praxis.
Results were identical to the original analyses (using CTS; data
not shown).
DISCUSSION
To the best of our knowledge, NU-AGE is the first multicenter
RCT assessing the effect of a culturally adapted, individually
tailored, Mediterranean-like whole-diet (dietary intervention
vs. control groups) on global cognition and specific cognitive
domains among relatively healthy older adults. In this study,
we found that all participants showed improvements in
their cognitive performance over 1-year follow-up, but no
additional diet-related cognitive improvements were evident in
the intervention arm. However, participants in the intervention
group with the higher adherence to the NU-AGE diet had
significantly improved global cognition, in particular episodic
memory, after the intervention. Our findings suggest that a
greater adherence to the individually tailored NU-AGE diet
might slow cognitive decline, and thereby may help to prevent
cognitive impairment and dementia.
To our knowledge, only three RCTs (PREDIMED, ENCORE,
and MedLey) have previously assessed the effects of a
Mediterranean dietary pattern on cognition in older adults in
Mediterranean and non-Mediterranean countries (Smith et al.,
2010; Valls-Pedret et al., 2015; Knight et al., 2016b). In the
PREDIMED (Prevención con Dieta Mediterránea), 578 Spanish
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TABLE 4 | Estimated mean change in global and domain-specific cognitive functioning (β-coefficients) and 95% confidence intervals by tertiles [1 (reference) to 3,
corresponding to low to high adherence] to the NU-AGE diet over 1-year of follow-up, among the intervention group (n = 638).
Cognitive functions Adherence to the NU-AGE diet
1st tertile (low) 2nd tertile 3rd tertile (high)
β (95% CI)a β (95% CI)a β (95% CI)a
CTS
Baseline 1.66 (0.27, 3.05) −0.24 (− 0.49, 0.01) −0.24 (−0.48,−0.003)b
Adherence × time 0.14 (− 0.02, 0.31) 0.20 (0.004, 0.39)b 0.16 (− 0.02, 0.35)c
Perceptual speed
Baseline 3.21 (2.16, 4.28) 0.06 (− 0.12, 0.24) 0.07 (− 0.10, 0.24)
Adherence × time 0.09 (− 0.03, 0.20) −0.04 (− 0.18, 0.09) −0.04 (− 0.17, 0.08)
Executive functions
Baseline 1.81 (0.73, 2.91) −0.06 (− 0.28, 0.15) −0.14 (− 0.34, 0.07)
Adherence × time 0.19 (− 0.01, 0.38) 0.04 (− 0.18, 0.27) −0.05 (− 0.26, 0.16)
Episodic memory
Baseline 0.70 (− 0.45, 1.85) −0.11 (− 0.31, 0.10) −0.11 (− 0.30, 0.08)
Adherence × time 0.05 (− 0.07, 0.17) 0.12 (− 0.02, 0.26) 0.15 (0.02, 0.28)b
Verbal abilities
Baseline 2.56 (1.17, 3.95) −0.07 (− 0.33, 0.18) −0.001 (− 0.24, 0.24)
Adherence × time 0.02 (− 0.15, 0.20) 0.11 (− 0.10, 0.31) 0.07 (− 0.13, 0.26)
Constructional praxis
Baseline 0.17 (− 1.06, 1.40) −0.06 (− 0.29, 0.18) 0.03 (− 0.20, 0.25)
Adherence × time −0.22 (− 0.44, 0.01) 0.15 (− 0.12, 0.42) 0.07 (− 0.18, 0.32)
CTS, CERAD total score.
aMixed-effect models were adjusted for baseline age, sex, education, enrollment country, and interviewer.
bp-value < 0.05.
cp-value = 0.08.
older adults, aged 55–80 years and at-risk of cardiovascular
diseases (CVD), were randomly assigned to three arms
(intervention groups: Mediterranean diet plus supplemented
olive oil and Mediterranean diet plus supplemented nuts;
control: standard low-fat diet) and were followed for 5
years. Participants allocated in the intervention groups showed
cognitive improvements in response to the Mediterranean
dietary pattern (Valls-Pedret et al., 2015). Furthermore, the 38
American older participants at-risk of CVD in the ENCORE
(Exercise andNutrition Interventions for Cardiovascular Health)
trial showed slight improvements in psychomotor speed
after 4-months intervention with the blood pressure-lowering
Mediterranean-like DASH diet (emphasizing dairy consumption
and restricted intake of sodium, commercial sweets, and
saturated fat; Morris, 2016), compared with 43 controls
who maintained their usual dietary habits (Smith et al.,
2010). Conversely, no cognitive improvements were detected
in 70 Australian healthy older volunteers, who followed a
Mediterranean diet for 6 months (Knight et al., 2016b). In
the NU-AGE trial, participants in the individually tailored
dietary intervention arm showed a tendency toward global
cognitive improvements after the 1-year intervention, but
these changes were not significant when compared to the
control group. Discrepancies in findings might be attributed
to methodological differences related to the study sample (e.g.,
non-healthy vs. healthy older adults; small sample size), not
high enough average adherence to diet in the whole intervention
group, or, in particular, to the short duration of the dietary
intervention. Indeed, the previous cohort studies have observed
neurocognitive benefits over longer periods of time (up to 13
years; Féart et al., 2009; Morris et al., 2015; Trichopoulou et al.,
2015).
Our findings are in line with previous community-
based observational studies linking higher adherence to a
Mediterranean diet or a similar dietary patterns with decreased
cognitive decline (Solfrizzi et al., 2017). Greater adherence
to a traditional Mediterranean diet was associated with
lower cognitive decline over 5-to-8 years of follow-up in two
prospective Mediterranean cohorts of older adults in France
(Féart et al., 2009) and Greece (Trichopoulou et al., 2015).
Similar results were also observed in non-Mediterranean
countries. Tangney and colleagues (Tangney et al., 2011, 2014)
reported slower rates of cognitive decline associated with a
greater adherence to a Mediterranean diet in two cohorts
of older individuals. A few studies in non-Mediterranean
countries using culturally adapted healthy diets, based on the
Mediterranean diet model, have reported similar relations.
Recent findings from the MIND diet, which combined the
Mediterranean and DASH diets with emphasis on green leafy
vegetables and berries, showed reduced rates of cognitive decline
Frontiers in Physiology | www.frontiersin.org 8 April 2018 | Volume 9 | Article 349
Marseglia et al. NU-AGE Dietary Intervention and Cognition
FIGURE 2 | Estimated trajectories of change in global cognition (A) and
episodic memory (B) among participants in the intervention group (n = 638)
with low (first tertile, reference) to high (third tertile) adherence levels to the
NU-AGE dietary intervention. Mixed-effect models were adjusted for baseline
age, sex, education, country, and interviewer. The trajectories were plotted
using the mean values of the covariates. CTS, CERAD total score.
in older individuals with increasing scores in the MIND diet
(Morris et al., 2015). In Northern Europe, higher adherence to
a Prudent diet (similar to the Mediterranean dietary pattern)
was related to less cognitive decline over 6 years in a cohort of
Swedish older adults (Shakersain et al., 2016). Interestingly, the
authors observed that a more frequent intake of the Prudent
diet, regardless of combining it with a less healthy Western diet
(characterized by more red/processed meat, saturated/trans-fat,
refined grains, sugar, beer, and spirit consumption), might still
have neuroprotective benefits (Shakersain et al., 2016). Despite
these positive findings, other observational studies did not detect
significant associations between Mediterranean-like dietary
patterns and cognitive health neither in Mediterranean countries
(Psaltopoulou et al., 2008) nor in other countries (Cherbuin
and Anstey, 2012; Samieri et al., 2013a,b). These inconsistent
findings can be attributed to differences in the study population
(e.g., inclusion of incident dementia or cognitive impairment),
assessment of dietary intake (self-reported questionnaire,
diaries, or more objective but less specific biomarkers) or dietary
patterns (a posteriori vs. a priori), assessment of cognitive decline
(screening tools such as MMSE rather than cognitive battery),
or variation in baseline age of study populations and follow-up
duration.
We also showed that a greater adherence to the NU-AGE diet
was related, in particular, to improvements in episodic memory
performance after intervention. Episodic memory impairment, a
core feature of the typical Alzheimer’s disease-related dementia
(AD) phenotype, generally depends on large-scale brain networks
of the medial temporal lobe, which includes the hippocampus
(Dickerson and Eichenbaum, 2010; Dubois et al., 2010). In recent
neuroimaging studies, higher adherence to Mediterranean-like
diets was related to larger cerebral and hippocampal volumes
over a period of up to 4-years (Gu et al., 2015; Jacka et al., 2015),
supporting the potential neuroprotective benefits of healthy diets.
The mechanisms underlying the neuroprotective benefits
linked to Mediterranean-like dietary patterns are largely
unknown; however, some hypotheses have been put forward.
At the systemic level, Mediterranean-like dietary patterns
may improve cognition indirectly through cardiovascular
improvements (Valls-Pedret et al., 2015). At the biochemical
level, healthy dietary patterns are associated with decreased
levels of oxidative stress, inflammatory biomarkers (Martucci
et al., 2017), insulin resistance, and blood glucose (Knight
et al., 2016a). Therefore, it has been proposed that synergistic
interactions between inflammatory, oxidative stress-related and
metabolic mechanismsmay underlie the neuroprotective benefits
of healthy dietary patterns (Vitale et al., 2013). Foods, such
as fruits (e.g., berries, grapes, and nuts), vegetables (e.g., dark-
leaf vegetables), whole grains, legumes/beans, fish (e.g., salmon,
sardines, herring, tuna), and olive oil are rich in several potent
dietary nutrients with antioxidant properties (vitamins A–E,
omega-3 fatty acids, MUFAs, and flavonoids; Knight et al.,
2016a). Higher intake of antioxidant nutrients is associated with
reduced oxidative stress and neuro-inflammation, which are
two key biological mechanisms of cognitive and brain aging
(Fusco et al., 2007; Liu et al., 2017). Deficiency in antioxidants,
overproduction of free radicals (e.g., reactive oxygen species,
ROS), and/or ROS accumulation in the cells, might induce
cellular oxidative damage, which over time leads to apoptotic
neuronal death and, thus, to accelerated cognitive decline and
dementia (Fusco et al., 2007; Calabrese et al., 2017; Liu et al.,
2017). Furthermore, ROS accumulation can activate, directly
or indirectly, specific proteins that trigger neuro-inflammation
(Vitale et al., 2013). Chronic neuro-inflammation is associated
with impaired microglia phagocytic capacity and astrocyte
dysfunction—two major sources of increased concentration of
inflammatory cytokines (e.g., TNFα, interlukine 1)—favoring
amyloid-beta (Aβ) deposits, decreasing cerebral blood flow,
and consequently, impairing adult neurogenesis (Heneka et al.,
2015; Knight et al., 2016a). Animal studies can provide further
understanding of the biochemical or structural brain effects
related to specific types of diet, such as Mediterranean-like diets,
thus partially explaining the observed cognitive improvements.
In a study investigating the lipid profile and neuropeptidase
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activities in the cortex of rats fed with foods supplemented in
fatty acids, particularly fish oil (rich in PUFA) or olive oil (rich in
MUFA), results showed that the distribution of fatty acids in the
cortex reflected the diet composition, which in turn influenced
brain functioning (Segarra et al., 2011). The authors suggested
that the lipids in the diet (especially higher concentration of
omega-3 PUFAs) may change the membrane fluidity, which in
turn will change the brain enzyme structure and activity, leading
to changes in brain function (Segarra et al., 2011). Future studies
need to investigate to what extent diets enriched in fatty acids
can induce similar biochemical and functional changes in human
brains.
The strengths of this study include: (1) the RCT study
design; (2) community-driven, relatively large sample of healthy
older adults from five Mediterranean and non-Mediterranean
European countries; (3) use of food diary records, which
minimize the reliance on memory to assess the usual food
intake (Berendsen et al., 2014); (4) extensive baseline and
post-intervention cognitive assessments including validated
tests; (5) good compliance with the intervention and low
overall dropout rates; and (6) the adjustment for multiple
potential confounders, including possible confounding related
to enrollment in different centers. Additionally, NU-AGE’s
multicenter recruitment not only allowed for a larger sample size,
but also overcame the issue related to the cultural-dependence
of Mediterranean-like dietary habits. On the other hand, some
limitations must be acknowledged. First, the 1-year duration
of the intervention might have been insufficient to detect
significant cognitive improvements in the intervention group
compared to controls. Indeed, at the follow-up examination,
participants in the intervention group showed a tendency
toward improved cognitive performance compared to controls,
but differences were small and not statistically significant.
Future dietary trials, in which real changes in food intake are
accomplished, require a longer intervention duration to observe
significant effects of cognition. Second, as participants in the
control group received a leaflet with national dietary guidelines,
they may have changed their habitual dietary behavior closer
to the healthier NU-AGE diet. However, this is unlikely as
in the control group the adherence to the national dietary
guidelines was similar at baseline and follow-up (51.5 and
52.7%, respectively). Third, enrollment of selected volunteers,
based on eligibility criteria in NU-AGE trial, might have
introduced a selection bias, leading to an underestimation
in the strength of the associations. Selective loss to follow-
up (dropouts) might have also introduced a second source
of bias. Compared to participants, dropouts at follow-up
were less healthy and had lower cognitive functioning at
baseline, meaning that the observed effect magnitudes could
have been underestimated. However, in the mITT analyses
(excluding dropouts) the magnitudes of the effects of the NU-
AGE diet on cognitive functioning were more similar to the
ITT analyses (including dropouts). Fourth, because the NU-
AGE intervention included both daily vitamin D supplements
and dietary advice, it is difficult to disentangle how much
each part contributed to the neurocognitive effects. Finally,
potential residual confounding—that is a common concern
in all epidemiological (both observational and interventional)
studies—cannot be ruled out. Taking into account the above
strengths and limitations, we believe that findings from the
NU-AGE’s individually tailored intervention can be generalized
to healthy European older individuals with features similar to
NU-AGE.
In summary, an individually tailored NU-AGE dietary
intervention that highly adheres to the nutritional principles
of the Mediterranean diet could be an effective preventive
strategy for cognitive impairment and dementia in countries
with different nutritional habits. However, long-duration
interventions are needed to confirm the neurocognitive benefits
possibly related to the NU-AGE diet. Future research is needed
to better understand how long the cognitive benefits can be
maintained after the trial is completed, and if it exists, whether
there is a ceiling threshold after which no intervention-related
cognitive benefit can be observed. Finally, to improve prevention
of multi-etiological disorders such as dementia, future trials
need to understand whether changes in nutritional behaviors
correspond to modification in other lifestyle behaviors (e.g.,
physical activity and social life) and how these lifestyle multi-
components interact with each other in diminishing dementia
risk.
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